Hypertension trials update

被引:12
作者
Al Ghorani, Hussam [1 ]
Kulenthiran, Saarraaken [1 ]
Lauder, Lucas [1 ]
Bohm, Michael [1 ]
Mahfoud, Felix [1 ]
机构
[1] Saarland Univ, Univ Klinikum Saarlandes, Klin Innere Med Kardiol Angiol & Internist Intens, Homburg, Germany
关键词
ACHIEVED BLOOD-PRESSURE; RESISTANT HYPERTENSION; HYDROCHLOROTHIAZIDE USE; DOUBLE-BLIND; ASSOCIATION; MORTALITY; RISK; DENERVATION; ADULTS;
D O I
10.1038/s41371-020-00477-1
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Hypertension is one of the most prevalent cardiovascular diseases and its treatment requires multimodal therapeutic approaches. This review aims to provide a summary and update on relevant evidence in hypertension research published in 2019/2020. These include trials dealing with the prognostic effect of systolic and diastolic blood pressure values, the association between hypertension and valve disease, reproducibility of masked and white-coat hypertension, and the prognostic importance of ambulatory and night-time blood pressure measurements. Treatment of hypertension focusing on elderly patients but also the potential cancer risk of thiazide diuretics, the valsartan recall, chronotherapy, and device-based hypertension therapy are discussed.
引用
收藏
页码:398 / 409
页数:12
相关论文
共 36 条
[1]   Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial [J].
Agarwal, Rajiv ;
Rossignol, Patrick ;
Romero, Alain ;
Garza, Dahlia ;
Mayo, Martha R. ;
Warren, Suzette ;
Ma, Jia ;
White, William B. ;
Williams, Bryan .
LANCET, 2019, 394 (10208) :1540-1550
[2]  
[Anonymous], 2019, GRENZWERTE NITROSAMI, V116
[3]  
[Anonymous], 2020, REV MET REN ART DAM
[4]  
Arzneimittelkommission der Deutschen Arzteschaft, 2018, HYDR RIS NICHTM HAUT, P1
[5]   A Controlled Trial of Renal Denervation for Resistant Hypertension [J].
Bhatt, Deepak L. ;
Kandzari, David E. ;
O'Neill, William W. ;
D'Agostino, Ralph ;
Flack, John M. ;
Katzen, Barry T. ;
Leon, Martin B. ;
Liu, Minglei ;
Mauri, Laura ;
Negoita, Manuela ;
Cohen, Sidney A. ;
Oparil, Suzanne ;
Rocha-Singh, Krishna ;
Townsend, Raymond R. ;
Bakris, George L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (15) :1393-1401
[6]   Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials [J].
Boehm, Michael ;
Schumacher, Helmut ;
Teo, Koon K. ;
Lonn, Eva M. ;
Mahfoud, Felix ;
Mann, Johannes F. E. ;
Mancia, Giuseppe ;
Redon, Josep ;
Schmieder, Roland E. ;
Sliwa, Karen ;
Weber, Michael A. ;
Williams, Bryan ;
Yusuf, Salim .
LANCET, 2017, 389 (10085) :2226-2237
[7]  
Bohm M, 2020, LANCET, V6736, P1
[8]  
Bundesinstitut fur Arzneimittel und Medizinprodukte (BfArM), 2018, ROT HAND BRIEF HYDR, P1
[9]   Resistant hypertension: Diagnosis, evaluation, and treatment - A Scientific Statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research [J].
Calhoun, David A. ;
Jones, Daniel ;
Textor, Stephen ;
Goff, David C. ;
Murphy, Timothy P. ;
Toto, Robert D. ;
White, Anthony ;
Cushman, William C. ;
White, William ;
Sica, Domenic ;
Ferdinand, Keith ;
Giles, Thomas D. ;
Falkner, Bonita ;
Carey, Robert M. .
HYPERTENSION, 2008, 51 (06) :1403-1419
[10]   Control of blood pressure and risk of mortality in a cohort of older adults: the Berlin Initiative Study [J].
Douros, Antonios ;
Toelle, Markus ;
Ebert, Natalie ;
Gaedeke, Jens ;
Huscher, Doerte ;
Kreutz, Reinhold ;
Kuhlmann, Martin K. ;
Martus, Peter ;
Mielke, Nina ;
Schneider, Alice ;
Schuchardt, Mirjam ;
van der Giet, Markus ;
Schaeffner, Elke .
EUROPEAN HEART JOURNAL, 2019, 40 (25) :2021-2028